| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/11/2013 | CN102499968B Drug for treating diabetes and preparation method thereof |
| 09/11/2013 | CN102423298B Preparation method of core-shell structure collagen polypeptide chelated calcium nanoparticle |
| 09/11/2013 | CN102406952B Application of <11>C-bicarbonate injection in preparation of acid-base imbalance positron emission tomography (PET) medicament |
| 09/11/2013 | CN102366518B Method for ultrasonic assisted aqueous two-phase extraction of total dioscin |
| 09/11/2013 | CN102293780B Sodium acetate Ringer's injection and preparation method thereof |
| 09/11/2013 | CN102283977B Sulphur fumigating method for cinnamomvine |
| 09/11/2013 | CN102277400B Extract containing beta-1,3-D-glucan and use thereof |
| 09/11/2013 | CN102216318B 抗氧化剂 Antioxidants |
| 09/11/2013 | CN102143741B Uses of sesquiterpene derivatives |
| 09/11/2013 | CN102139002B Cortex phellodendri polysaccharide extract and preparation method and medical application thereof |
| 09/11/2013 | CN102093598B Composite edible fungi polysaccharides and preparation method thereof |
| 09/11/2013 | CN102050846B Amino sugar, and preparation method and use thereof |
| 09/11/2013 | CN102046600B New crystalline pyrithione/zinc oxide complex and physiologic/antibiotic active composite containing the same |
| 09/11/2013 | CN102038887B Formula of functional proteome for quickly supplementing human albumin and preparation method thereof |
| 09/11/2013 | CN101981009B 2-trifluoromethylnicotinamide derivatives as HDL-cholesterol raising agents |
| 09/11/2013 | CN101909639B Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy |
| 09/11/2013 | CN101829300B Hyperthermia agent with high thermal efficiency and multiple functions |
| 09/11/2013 | CN101516877B 杂环有机化合物 Heterocyclic compounds |
| 09/10/2013 | US8530648 Diaza-spiro[5.5]undecanes |
| 09/10/2013 | US8530448 Compounds and methods for inhibiting selectin-mediated function |
| 09/10/2013 | US8530447 Dietary fiber formulation and method of administration |
| 09/10/2013 | US8530438 Vivo production of small interfering RNAs that mediate gene silencing |
| 09/10/2013 | US8530407 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 09/10/2013 | US8530225 Therapeutic agents comprising pro-apoptotic proteins |
| 09/10/2013 | US8529940 Dietary method for modulating glucose metabolism |
| 09/10/2013 | US8529884 Using vector transformation to express herpes simple-1 viral gene sequences in cells; inducing immune response to pathogen attack |
| 09/10/2013 | CA2758894C Novel thyroid hormone .beta. receptor agonist |
| 09/10/2013 | CA2755452C Method of regulating glucose metabolism, and reagents related thereto |
| 09/10/2013 | CA2669687C Phthalazine derivatives |
| 09/10/2013 | CA2649111C Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 09/10/2013 | CA2627837C Pharmaceutical compositions for alleviating discomfort |
| 09/10/2013 | CA2614544C Heterocycle-substituted benzimidazole derivative |
| 09/06/2013 | WO2013131091A1 Chimeric fgf21 proteins with enhanced binding affinity for beta-klotho for the treatment of type ii diabetes, obesity and related metabolic disorders |
| 09/06/2013 | WO2013130855A1 Indazole derivatives |
| 09/06/2013 | WO2013130577A2 Compositions and methods for the treatment of migraine |
| 09/06/2013 | WO2013130411A1 Salts of potassium atp channel openers and uses thereof |
| 09/06/2013 | WO2013128465A1 Cyclic amide derivatives as inhibitors of 11 - beta - hydroxysteroid dehydrogenase and uses thereof |
| 09/06/2013 | WO2013128450A1 Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes |
| 09/06/2013 | WO2013128391A1 Synthetic polypeptides and uses thereof |
| 09/06/2013 | WO2013128378A1 Phenyl alkanoic acid derivatives as gpr agonists |
| 09/06/2013 | WO2013128000A1 Novel crystalline form of sitagliptin sulfate |
| 09/06/2013 | WO2013127828A1 Furo [2, 3 -c] pyridines actives on gpr 119 |
| 09/06/2013 | WO2013127268A1 Amido-benzyl sulfone and sulfonamide derivatives |
| 09/06/2013 | WO2013127267A1 Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives |
| 09/06/2013 | WO2013078564A3 Targeted lysosomal enzyme compounds |
| 09/06/2013 | WO2013078562A3 Targeted iduronate-2-sulfatase compounds |
| 09/05/2013 | US20130230501 Cycloalkyl-Substituted Imidazole Derivative |
| 09/04/2013 | EP2634184A1 C-arylglucoside derivative, preparation method therefor, and use thereof |
| 09/04/2013 | EP2633884A1 Obesity small molecules |
| 09/04/2013 | EP2632945A1 Glucose-dependent insulinotropic peptide analogs |
| 09/04/2013 | EP2632933A1 Glycyrrhetinic acid amine analogues for use in the treatment of inflammation, infectious diseases, cancer, autoimmune diseases, skin diseases, bone diseases and metabolic diseases |
| 09/04/2013 | EP2632919A2 Pyrazole compounds |
| 09/04/2013 | EP2632456A1 Composition and method for influencing energy metabolism and treating metabolic and other disorders |
| 09/04/2013 | CN103282054A A pharmaceutical composition of a complex of an anti-ig antibody and digoxigenin that is conjugated to a peptide |
| 09/04/2013 | CN103282031A New pharmaceutical compositions comprising a thyroid hormon and their therapeutic use |
| 09/04/2013 | CN103282030A Pharmaceutical composition, methods for treating and uses thereof |
| 09/04/2013 | CN103275984A MCP-1 binding nucleic acids |
| 09/04/2013 | CN103275905A Lactobacillus rhamnosus CCFM0528 having diabetes preventing effect |
| 09/04/2013 | CN103275901A Space-induced efficient bacillus natto, application of bacillus natto and preparation method of troche of bacillus natto |
| 09/04/2013 | CN103275856A Health liquor |
| 09/04/2013 | CN103275843A Brewing process added with lotus leaf |
| 09/04/2013 | CN103275221A Human antibodies that bind human tnf alpha |
| 09/04/2013 | CN103275169A Furostanol saponins and synthesis method thereof |
| 09/04/2013 | CN103275083A Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 09/04/2013 | CN103275044A R type resveratrol oligomer as well as preparation method and blood sugar decreasing application thereof |
| 09/04/2013 | CN103274985A Atorvastatin amino acid salts |
| 09/04/2013 | CN103274961A Compositions and methods of treating cell proliferation disorders |
| 09/04/2013 | CN103272248A Application of miR-15b in preparing diabetes diagnosis and treatment preparation |
| 09/04/2013 | CN103272245A Curcumin and mixed-cyclodextrin inclusion compound and preparation method thereof |
| 09/04/2013 | CN103272171A Traditional Chinese medicine for treating hopatolenticular degeneration and its preparation method and use |
| 09/04/2013 | CN103272125A Traditional Chinese medicine composition containing dendrobium huoshanense and having hypoglycemic effect, and preparation method thereof |
| 09/04/2013 | CN103272105A Tablet for treating diabetic nephropathy |
| 09/04/2013 | CN103272079A Hui medicine compound for treating diabetic nephropathy and application thereof |
| 09/04/2013 | CN103272009A Medicine for treating cardiovascular and cerebrovascular diseases and preparation method of medicine |
| 09/04/2013 | CN103271978A Ginkgo leaf compound preparation for resisting oxygen deprivation and glucose deprivation and treating altitude sickness |
| 09/04/2013 | CN103271975A Application of grosvenor momordica fruit sweet essence to treatment of impaired glucose tolerance (IGT) |
| 09/04/2013 | CN103271968A Blood glucose reduction use of kardiseed dreg extractive |
| 09/04/2013 | CN103271963A Calliopsis elegans aqueous extract and medical application thereof |
| 09/04/2013 | CN103271940A Compound metal ion replenisher and preparation method thereof |
| 09/04/2013 | CN103271907A Oral medicine composition consisting of berberine and melbine, and preparation method thereof |
| 09/04/2013 | CN103271906A Use of spiro-oxindole compounds as therapeutic agents |
| 09/04/2013 | CN103271904A Nitric oxide donor endothelin receptor antagonist as well as preparation method and application thereof |
| 09/04/2013 | CN103271903A Novel medical use of icaritin and cycloicaritin as well as composition thereof |
| 09/04/2013 | CN103271902A Slightly-soluble medicine solid dispersion and preparation method thereof |
| 09/04/2013 | CN103271900A Zinc citrate tablet and preparation method thereof |
| 09/04/2013 | CN103271832A Synephrine loaded multiple emulsion and preparation method thereof |
| 09/04/2013 | CN103271339A Health care capsule |
| 09/04/2013 | CN102716303B Chinese medicinal composition for treating nephritic syndrome and preparation method thereof |
| 09/04/2013 | CN102614258B Chinese medicinal composition with blood sugar reducing effect, and preparation method and application thereof |
| 09/04/2013 | CN102358735B Low toxicity multiple-point guided drug, nitrogen-containing aromatic ring CB1 receptor inhibitor with hydroxyl or substituted hydroxyl, and pharmaceutical use thereof |
| 09/04/2013 | CN102250935B Recombinant transgenic vector carrying human insulin-like growth factor-I and use thereof |
| 09/04/2013 | CN102066342B Quinoxalinedione derivatives |
| 09/04/2013 | CN101987868B Derivative or pharmaceutically acceptable salt of GLP-1 analogue and application of derivative or pharmaceutically-acceptable salt of a GLP-1 analogue |
| 09/04/2013 | CN101837003B Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
| 09/04/2013 | CN101631477B Liquid nutritional food and method of producing the same |
| 09/04/2013 | CN101356968B Red Chinese fevervine extract and medical composition thereof and food composition and preparation method thereof |
| 09/03/2013 | US8524871 Modified gherlin peptides |
| 09/03/2013 | US8524773 Utilization of dialkylfumarates |
| 09/03/2013 | US8524720 Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors |
| 09/03/2013 | US8524711 Amino-derivatives as novel inhibitors of histone deacetylase |